MMSET Inhibitor

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Near Add Your Location

Sorting 20 by

Memorial Sloan Kettering Cancer Center
New York, NY
  • Accepting patients
  • Show Principal Investigator
Duke Cancer Center
Duke University Medical Center
Durham, NC
  • Accepting patients
  • Show Principal Investigator
Dana-Farber Cancer Institute
Boston, MA
  • Accepting patients
  • Show Principal Investigator
The University of Texas Southwestern Medical Center
Harold C. Simmons Comprehensive Cancer Center
Dallas, TX
  • Accepting patients
  • Show Principal Investigator
Winship Cancer Institute
Emory University
Atlanta, GA
  • Accepting patients
  • Show Principal Investigator
UCSF Helen Diller Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA
  • Accepting patients
  • Show Principal Investigator
Massachusetts General Hospital
Boston, MA
  • Accepting patients
  • Show Principal Investigator
Mayo Clinic (Jacksonville)
Jacksonville, FL
  • Accepting patients
  • Show Principal Investigator
Memorial Sloan Kettering Bergen
Montvale, NJ
  • Accepting patients
  • Show Principal Investigator
Memorial Sloan Kettering Commack
Commack, NY
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.